Recent research has focused on designing components that simultaneously combine therapeutic agents and targeted disease sites, resulting in devices that respond dynamically to specific cues that trigger drug release. Immunoliposomes have been considered as attractive drug targeting carriers for cancer treatment, and Creative Biolabs offers professional immunoliposome customization services to solve customer problems. Protein engineering advancements have revolutionized nanomedicine by introducing new nanocarriers to deliver cancer therapeutics.
For more information: Immunoliposome Development Service